Joint Corp Stock Price, News & Analysis

The Joint Corp. (NASDAQ:JYNT), a prominent chiropractic clinic operator, announced its participation in the 18th Annual Craig-Hallum Institutional Investor Conference on June 2, 2021. CEO Peter D. Holt and CFO Jake Singleton will conduct one-on-one meetings with institutional investors. The Joint has over 600 locations and facilitates more than eight million patient visits annually, making chiropractic care accessible and affordable without requiring insurance.

Recognized in Franchise Times' "Top 200+ Franchises" and Entrepreneur's "Franchise 500®" lists, The Joint continues to innovate in the retail healthcare sector.

The Joint Corp. (NASDAQ:JYNT) announced its inclusion in the S&P SmallCap 600 effective May 27, 2021. This recognition reflects the company's efforts to enhance access to chiropractic care through a retail model, emphasizing quality and affordability without insurance. President and CEO Peter D. Holt highlighted the commitment of the entire team towards improving patient quality of life. The S&P SmallCap 600 tracks financially viable small-cap companies, showcasing the growth potential of The Joint in the chiropractic industry, which includes over 600 locations and 8 million annual patient visits.

On May 24, 2021, S&P Dow Jones Indices announced that The Joint Corp. (JYNT) will replace Cubic Corp. (CUB) in the S&P SmallCap 600 index effective May 27, 2021. This change is part of an acquisition process where Veritas Capital is acquiring Cubic, pending final closing conditions. The addition of The Joint Corp. represents a strategic shift in the index, as it falls under the Health Care sector, unlike Cubic, which is in the Industrials sector.

The Joint Corp. (NASDAQ: JYNT) has opened its 600th chiropractic clinic, marking a significant growth milestone for the company. This new location in Bowling Green, KY, represents the first The Joint Chiropractic clinic in the state, contributing to a network that now spans 34 states. The company aims to reach 1,000 clinics by the end of 2023, highlighting its expanding footprint and commitment to accessible chiropractic care. The growth reflects consumer demand for affordable wellness solutions, particularly post-pandemic, reinforcing the robustness of The Joint's business model.

The Joint Corp. (NASDAQ: JYNT) reported significant financial growth for Q1 2021, achieving a 29% increase in revenue to $17.5 million compared to Q1 2020. System-wide sales rose by 28% to $77.8 million, while comparable sales increased by 21%. Operating income surged 162% to $2.0 million, and Adjusted EBITDA rose 108% to $3.5 million. The company also updated its guidance for 2021, projecting revenues between $73.5 million and $77.5 million, indicating a strong outlook for future growth.

The Joint Corp. (NASDAQ: JYNT) is promoting National Posture Month this May, emphasizing the importance of spine health. With many Americans working from home, poor posture has become a significant health issue, contributing to back pain and other health problems. Dr. Steven Knauf highlights that 80% of Americans will experience back pain in their lifetime. The Joint Chiropractic offers chiropractic treatments, exercise, and nutrition tips to improve posture. With over 550 clinics nationwide, they provide convenient, affordable care without insurance hassles.

The Joint Corp. (NASDAQ: JYNT) will announce its first quarter 2021 financial results on May 6, 2021, post-market. CEO Peter D. Holt and CFO Jake Singleton will host a conference call at 5:00 p.m. ET to discuss these results. Interested parties can join the call by calling 765-507-2604 or 844-464-3931, using access code 6699865. The live webcast and accompanying slides will be available in the Investor Relations section of their website. The Joint, a leading provider of chiropractic care, aims to make quality treatment more accessible without insurance.

The Joint Corp. (NASDAQ: JYNT) announced that it has expanded its corporate clinic operations, increasing the number of managed clinics to 74 as of April 1, 2021. The company opened new clinics in Los Angeles, CA, and Yuma, AZ, and acquired eight previously franchised clinics, enhancing its presence in Phoenix/Scottsdale and North Carolina. These acquisitions, part of a strategic growth plan aimed at 1,000 clinics by the end of 2023, are expected to be accretive to earnings. CEO Peter D. Holt highlighted the company's commitment to expanding its clinic clusters despite initial earnings suppression from new greenfield openings.

The Joint Corp. (NASDAQ: JYNT) reported robust financial results for Q4 and the full year 2020, with revenue growth of 23% quarterly and 21% annually. Operating income reached a record $5.5 million, a 61% increase from 2019, while Adjusted EBITDA also hit a record at $9.1 million, up 47% year-over-year. The clinic count rose to 579 with 21 new clinics opened in Q4, and franchised licenses sold surged to 56 in the same quarter, compared to 23 in Q4 2019. The company anticipates revenue between $73 million and $77 million for 2021.